Robert Lauzon

All filings by Robert Lauzon on record concern Middlefield Healthcare & Life Sciences Dividend Fund. We count 10 filings; the first trade dates from 21 July 2017 and the latest from 3 August 2018.

In open-market terms, that means 6 purchases worth €65k on one side and 2 sales worth €81k on the other. Netting one side against the other leaves €15k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2018: no purchases and 2 sales on the market.

Half of the purchases are above €10k and half below. The 6 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 8 August 2018 came the latest disclosure, an open-market sale for €14k in Middlefield Healthcare & Life Sciences Dividend Fund. The clock since the last published purchase (26 October 2017) now reads 3,288 days. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.